| Literature DB >> 31552144 |
Carlton A Hornung1,2, Phillip A Ianni3, Carolynn T Jones4, Elias M Samuels3, Vicki L Ellingrod3,5.
Abstract
INTRODUCTION: There is a clear need to educate and train the clinical research workforce to conduct scientifically sound clinical research. Meeting this need requires the creation of tools to assess both an individual's preparedness to function efficiently in the clinical research enterprise as well as tools to evaluate the quality and effectiveness of programs that are designed to educate and train clinical research professionals. Here we report the development and validation of a competency self-assessment entitled the Competency Index for Clinical Research Professionals, version II (CICRP-II).Entities:
Keywords: Assessment Tool; Clinical Research Coordinator; Clinical Research Professional; Core Competency; Exploratory Factor Analysis
Year: 2019 PMID: 31552144 PMCID: PMC6759060 DOI: 10.1017/cts.2019.381
Source DB: PubMed Journal: J Clin Transl Sci ISSN: 2059-8661
Fig. 1.Scree plot of the eigenvalues. Abbreviation: CICRP-II, Competency Index for Clinical Research Professionals, version II.
Twenty CICRP items administered to DIAMOND CTSA sites (N = 95)
| CICRP 20 Items | Routine | Advanced |
|
|---|---|---|---|
| EP3: Apply relevant national and international principles of human subject protections and privacy throughout all stages of a clinical study. |
| 8.15 (1.85) | |
| LP4: Describe the impact of diversity and demonstrate cultural competency in the design and conduct of clinical research. |
| 7.61 (2.34) | |
| DM5: Describe and develop processes for data quality assurance. |
| 7.34 (2.19) | |
| EP5: Describe the ethical issues involved when dealing with vulnerable populations and the need for additional safeguards. |
| 8.25 (1.88) | |
| LP3: Identify and apply the professional guidelines and codes of ethics related to the conduct of clinical research. |
| 8.20 (1.91) | |
| DM3: Describe and assess best practices and the importance of informatics for standardizing data collection, capture, management, analysis, and reporting. |
| 7.54 (2.11) | |
| SS3: Recognize the management and training approaches to mitigate risk to improve clinical study conduct. |
| 7.03 (2.26) | |
| SC5: Critically analyze clinical and translational study results. |
| 5.66 (2.79) | |
| CT6: Differentiate the types of adverse events (AEs) that may occur during clinical studies, explain the identification process for AEs, and describe the reporting requirements to IRBs/IECs, sponsors, and regulatory authorities. |
| 8.13 (1.94) | |
| EP1: Differentiate between standard of care and clinical study activities. |
| 8.57 (2.03) | |
| MD3: Explain the investigational products development process and the activities that integrate commercial realities into the life cycle management of medical products. |
| 5.03 (2.85) | |
| MD5: Describe the specific processes and phases that must be followed in order for the regulatory authority to approve the marketing authorization for a medical product. |
| 5.04 (3.08) | |
| CT8: Describe the reporting requirements of global regulatory bodies relating to clinical study conduct. |
| 5.32 (2.87) | |
| MD4: Summarize the legislative and regulatory framework that supports the development and registration of investigational products and ensures their safety, efficacy, and quality. |
| 4.64 (2.79) | |
| MD2: Describe the roles and responsibilities of the various institutions participating in the investigational product development process. |
| 6.06 (2.67) | |
| CT4: Compare and contrast the regulations and guidelines of global regulatory bodies relating to the conduct of clinical studies. |
| 4.88 (2.92) | |
| SS5: Identify the legal and regulatory responsibilities, issues, liabilities, and accountabilities that are involved in the conduct of clinical studies. |
| 6.78 (2.53) | |
| CT9: Describe the role and process for monitoring a study. |
| 7.60 (2.10) | |
| EP2: Define the concepts of clinical equipoise and therapeutic misconception as they relate to the conduct of clinical studies. |
| 4.63 (3.12) | |
| SC3: Explain the elements of clinical and translational study design. |
| 6.91 (2.50) |
Each competency statement is preceded by an abbreviation of one of the eight ECRPTQ core competency domains, and a number that indicates the original number for that competency statement. Abbreviations: CICRP, Competency Index for Clinical Research Professionals; CT, clinical trial operations; CTSA, clinical and translational science award; DM, data management and informatics; EP, ethical and participant safety considerations; LP, leadership and professionalism; MD, medicines development and regulation; SC, scientific concepts and research design; SS, study and site management.
SC3 had a higher loading on Factor 1 (0.454) but was included in Factor 2 to equalize the number of Items in each factor. This had inconsequential effects on scale reliability.
Correlations between factors with alternative scoring methods (DIAMOND Data; N = 95)
| Routine Regression | Advanced Regression | Routine Sum | Advanced Sum | Routine Count | Advanced Count | |
|---|---|---|---|---|---|---|
| Routine Regression | 1.000 | 0.687 | 0.991 | 0.695 | 0.899 | 0.663 |
| Advanced Regression | 1.000 | 0.688 | 0.986 | 0.601 | 0.921 | |
| Routine Sum | 1.000 | 0.688 | 0.901 | 0.660 | ||
| Advanced Sum | 1.000 | 0.609 | 0.931 | |||
| Routine Count | 1.000 | 0.627 | ||||
| Advanced Count | 1.000 |
Statistical characteristics with alternative scoring methods (DIAMOND Data; N = 95)
| Routine | Advanced | Routine | Advanced | Routine | Advanced | |
|---|---|---|---|---|---|---|
| Mean | 0.000 | 0.000 | 76.47 | 56.89 | 8.41 | 5.76 |
| Median | 0.177 | −0.034 | 79.00 | 56.00 | 9.00 | 6.00 |
| Standard Deviation | 0.97 | 0.97 | 16.08 | 20.66 | 2.32 | 3.16 |
| Minimum | −3.84 | −2.22 | 12.00 | 11.00 | 0.00 | 0.00 |
| Maximum | 1.37 | 1.90 | 100.00 | 100.00 | 10.00 | 10.00 |
| Cronbach’s Alpha | 0.913 | 0.911 | 0.856 | 0.862 |
Characteristics of CRCs in the JTF and Diamond survey data
| JTF | DIAMOND |
| |||
|---|---|---|---|---|---|
| N | % | N | % | ||
| Education | |||||
| ≤ Bachelor’s | 54 | 66.7 | 51 | 53.7 | |
| Master’s | 23 | 28.4 | 34 | 35.8 | |
| Doctorate | 4 | 4.9 | 10 | 10.5 | 0.158 |
| Clinical Research Degrees | |||||
| Yes | 6 | 7.4 | 21 | 22.3 | 0.012 |
| Years of Experience | |||||
| < 2 | 16 | 28.4 | 15 | 15.8 | |
| 2 – 5 | 21 | 25.8 | 43 | 45.3 | |
| 6 – 10 | 14 | 17.3 | 19 | 20.0 | |
| 11 – 20 | 21 | 25.9 | 13 | 13.7 | |
| > 20 | 9 | 11.1 | 5 | 5.3 | 0.035 |
| Professional Membership | |||||
| ACRP | 29 | 35.8 | 13 | 13.7 | <0.001 |
| Certified | 26 | 32.1/89.7 | 11 | 11.6/84.7 | |
| SoCRA | 16 | 19.8 | 30 | 31.6 | 0.075 |
| Certified | 13 | 16.0/81.2 | 27 | 28.4/90.0 | |
Abbreviations: ACRP, Association of Clinical Research Professionals; CRC, clinical research coordinators; JTF, Joint Task Force; SoCRA, Society of Clinical Research Associates.
Self-assessed competency of CRCs on CICRP-I and CICRP-II. [JTF (N = 81) and DIAMOND Surveys (N = 95)]
| Data Set | Mean | Standard deviation |
| |
|---|---|---|---|---|
| CICRP-I Factors | ||||
| General Clinical Research | JTF | 5.65 | 3.02 | |
| Medicines Development | JTF | 2.52 | 1.72 | |
| Ethics and Patient Safety | JTF | 3.89 | 1.22 | |
| Data Management | JTF | 3.17 | 1.66 | |
| Scientific Concepts | JTF | 2.04 | 1.67 | |
| CICRP-II Factors | ||||
| Routine Functions | JTF | 6.54 | 2.60 | |
| Advanced Functions | JTF | 4.58 | 2.96 | |
Abbreviations: CICRP, Competency Index for Clinical Research Professionals; CRC, clinical research coordinators; JTF, Joint Task Force.